IL166213A0 - N-hydroxyamide derivatives possessing antibacterial activity - Google Patents
N-hydroxyamide derivatives possessing antibacterial activityInfo
- Publication number
- IL166213A0 IL166213A0 IL16621305A IL16621305A IL166213A0 IL 166213 A0 IL166213 A0 IL 166213A0 IL 16621305 A IL16621305 A IL 16621305A IL 16621305 A IL16621305 A IL 16621305A IL 166213 A0 IL166213 A0 IL 166213A0
- Authority
- IL
- Israel
- Prior art keywords
- antibacterial activity
- derivatives possessing
- hydroxyamide derivatives
- possessing antibacterial
- hydroxyamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39486202P | 2002-07-11 | 2002-07-11 | |
PCT/US2003/021838 WO2004007444A2 (en) | 2002-07-11 | 2003-07-11 | N-hydroxyamide derivatives possessing antibacterial activity |
Publications (1)
Publication Number | Publication Date |
---|---|
IL166213A0 true IL166213A0 (en) | 2006-01-15 |
Family
ID=30115780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16621305A IL166213A0 (en) | 2002-07-11 | 2005-01-10 | N-hydroxyamide derivatives possessing antibacterial activity |
Country Status (8)
Country | Link |
---|---|
US (1) | US7691843B2 (ko) |
EP (1) | EP1539744A4 (ko) |
JP (1) | JP4617449B2 (ko) |
KR (1) | KR101011373B1 (ko) |
AU (1) | AU2003267991B2 (ko) |
CA (1) | CA2492035A1 (ko) |
IL (1) | IL166213A0 (ko) |
WO (1) | WO2004007444A2 (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2851462A1 (en) | 2003-01-08 | 2004-07-29 | University Of Washington | Antibacterial agents |
US7638513B2 (en) | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
CA2634005C (en) * | 2005-12-15 | 2012-01-03 | Vicuron Pharmaceuticals Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
JP2009525277A (ja) | 2006-01-30 | 2009-07-09 | グロボアジア エルエルシー | 軟組織石灰化の回復、予防、遅延または安定化方法 |
CA2661605A1 (en) * | 2006-08-31 | 2008-03-06 | Schering Corporation | Hydantoin derivatives useful as antibacterial agents |
CN107021895A (zh) * | 2007-06-12 | 2017-08-08 | 尔察祯有限公司 | 抗菌剂 |
EP2234608A2 (en) | 2007-12-11 | 2010-10-06 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
WO2011005355A1 (en) * | 2009-05-07 | 2011-01-13 | Achaogen, Inc. | Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria |
JP5167389B2 (ja) | 2010-07-07 | 2013-03-21 | 日本たばこ産業株式会社 | クエン酸第二鉄を含む錠剤 |
US9738604B2 (en) | 2010-09-03 | 2017-08-22 | Duke University | Ethynylbenzene derivatives |
CA2824646C (en) | 2011-01-18 | 2020-07-14 | Japan Tobacco Inc. | Ferric citrate containing substantially no .beta.-oxidized iron hydroxide |
WO2013170165A1 (en) | 2012-05-10 | 2013-11-14 | Achaogen, Inc. | Antibacterial agents |
WO2015024016A2 (en) | 2013-08-16 | 2015-02-19 | Duke University | 2-piperidinyl substituted n,3-dihydroxybutanamides |
JP6458270B2 (ja) | 2013-08-16 | 2019-01-30 | デューク ユニバーシティ | 置換されたヒドロキサム酸化合物 |
US10189786B2 (en) | 2013-08-16 | 2019-01-29 | Duke University | Antibacterial compounds |
CN105646321A (zh) * | 2016-01-07 | 2016-06-08 | 中国药科大学 | (s)-3-羟基吡咯烷盐酸盐的制备方法 |
ES2903079T3 (es) * | 2016-04-18 | 2022-03-31 | Vivoryon Therapeutics N V | Novedosos inhibidores de meprina alfa y beta |
UY38367A (es) | 2018-09-13 | 2020-04-30 | Syngenta Participations Ag | Compuestos de azol-amida pesticidamente activos |
JP2022116370A (ja) * | 2019-06-13 | 2022-08-10 | アグロカネショウ株式会社 | 新規な1-ベンジルアミン誘導体及びこれを有効成分とする農園芸用薬剤 |
WO2021122645A1 (en) * | 2019-12-20 | 2021-06-24 | Syngenta Crop Protection Ag | Pesticidally active azole-amide compounds |
TW202208347A (zh) | 2020-05-06 | 2022-03-01 | 德商拜耳廠股份有限公司 | 作為殺蟲劑之新穎雜芳基***化合物 |
CN112410449A (zh) * | 2021-01-25 | 2021-02-26 | 天津奇云诺德生物医学有限公司 | 一种与结直肠癌相关的微生物标志物及其应用 |
CN113413390B (zh) * | 2021-06-24 | 2022-08-30 | 河南大学 | 4-脱氧-n-乙酰氨基葡萄糖作为革兰氏阳性菌抗菌添加剂的应用 |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5098904A (en) | 1990-06-27 | 1992-03-24 | Bristol-Myers Squibb Company | Cerebral function enhancing pyrimidinyl derivatives |
SG52635A1 (en) | 1991-04-10 | 1998-09-28 | Mitsubishi Electric Corp | Encoder and decoder |
CA2071621C (en) | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
US6506876B1 (en) | 1994-10-11 | 2003-01-14 | G.D. Searle & Co. | LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
JPH11502224A (ja) | 1995-03-17 | 1999-02-23 | 藤沢薬品工業株式会社 | N−アシルピペリジニルカルボニルアミノカルボン酸、およびグリコプロテインIIB/IIIa拮抗剤およびフィブリノーゲン血小板凝集抑制剤としてのその用途 |
WO1996038471A1 (en) | 1995-05-29 | 1996-12-05 | Pfizer Inc. | Dipeptides which promote release of growth hormone |
NZ305940A (en) * | 1995-07-26 | 1999-05-28 | Pfizer | N-(aroyl)glycine hydroxamic acid derivatives and related compounds that inhibit the production of tnf and are useful in treating asthma |
US5997881A (en) | 1995-11-22 | 1999-12-07 | University Of Maryland, Baltimore | Method of making non-pyrogenic lipopolysaccharide or A |
TR199802207T2 (xx) | 1996-05-01 | 2001-06-21 | Ortho-Mcneil Pharmacetical, Inc. | Tromboz'a kar�� kullan�lmaya mahsus pirrolidin, piperidin ve heksahidroazepin'in karboksamid t�revleri. |
US5925659A (en) | 1996-05-07 | 1999-07-20 | Merck & Co., Inc. | Antibacterial agents |
DE19642591A1 (de) | 1996-10-15 | 1998-04-16 | Basf Ag | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
DE19647381A1 (de) * | 1996-11-15 | 1998-05-20 | Hoechst Ag | Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
TW542822B (en) | 1997-01-17 | 2003-07-21 | Ajinomoto Kk | Benzamidine derivatives |
DE69811867T2 (de) | 1997-03-03 | 2003-11-20 | Boehringer Ingelheim Pharma | Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten |
AR011913A1 (es) * | 1997-03-06 | 2000-09-13 | Yamano Masaki | Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos. |
US6492421B1 (en) * | 1997-07-31 | 2002-12-10 | Athena Neurosciences, Inc. | Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
EP1007033B1 (en) | 1997-08-28 | 2008-04-23 | Novartis AG | Lymphocyte function antigen-1 antagonists |
US20010039287A1 (en) | 1997-11-14 | 2001-11-08 | Thomas E Barta | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
WO1999025685A1 (en) | 1997-11-18 | 1999-05-27 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
DE19751251A1 (de) * | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
AU1411499A (en) | 1997-11-20 | 1999-06-15 | Merck & Co., Inc. | Para-aminomethylaryl carboxamide derivatives |
US6191171B1 (en) * | 1997-11-20 | 2001-02-20 | Merck & Co., Inc. | Para-aminomethylaryl carboxamide derivatives |
CA2318351A1 (en) | 1997-12-26 | 1999-07-08 | Hidemitsu Nishida | Aromatic compounds having cyclic amino or salts thereof |
US6407065B1 (en) * | 1998-01-23 | 2002-06-18 | Novartis Ag | VLA-4 antagonists |
WO1999052926A1 (en) | 1998-04-14 | 1999-10-21 | Versicor, Inc. | Regulated target expression for screening |
EP1085846A2 (en) | 1998-06-08 | 2001-03-28 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
TW591026B (en) | 1998-06-23 | 2004-06-11 | Upjohn Co | Inhibitors of alpha4beta1 mediated cell adhesion |
AU4701799A (en) * | 1998-07-21 | 2000-02-14 | Warner-Lambert Company | Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
US6331640B1 (en) | 1998-10-13 | 2001-12-18 | Hoffmann-La Roche Inc. | Diaminopropionic acid derivatives |
EP1004578B1 (en) * | 1998-11-05 | 2004-02-25 | Pfizer Products Inc. | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
US6110922A (en) | 1998-12-29 | 2000-08-29 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
WO2000043354A2 (en) * | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
CA2359112A1 (en) | 1999-01-22 | 2000-07-27 | Elan Pharmaceuticals, Inc. | Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
AU4192000A (en) | 1999-04-02 | 2000-10-23 | Abbott Laboratories | Lfa-1 regulatory binding site and uses thereof |
SK14022001A3 (sk) | 1999-04-02 | 2002-03-05 | Icos Corporation | Inhibítory väzby LFA-1 na ICAM a ich použitie |
UA74781C2 (en) | 1999-04-02 | 2006-02-15 | Abbott Lab | Antiinflammatory and immumosuppressive compounds inhibiting cell adhesion |
WO2001000616A1 (fr) | 1999-06-25 | 2001-01-04 | Mochida Pharmaceutical Co., Ltd. | Inhibiteurs de la biosynthese du cholesterol contenant comme ingredient actif des composes aromatiques porteurs de groupes cycliques amino |
WO2001007048A1 (en) | 1999-07-21 | 2001-02-01 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
US6365615B1 (en) | 1999-07-21 | 2002-04-02 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
MXPA02000625A (es) | 1999-07-21 | 2002-07-02 | Boehringer Ingelheim Pharma | Pequenas moleculas utiles en el tratamiento de enfermedades inflamatorias. |
US6353013B1 (en) | 1999-07-21 | 2002-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Small molecules useful in the treatment of inflammatory disease |
WO2001012183A1 (en) | 1999-08-16 | 2001-02-22 | Merck & Co., Inc. | Heterocycle amides as cell adhesion inhibitors |
WO2001014328A2 (en) | 1999-08-20 | 2001-03-01 | Merck & Co., Inc. | Substituted ureas as cell adhesion inhibitors |
JP2003508448A (ja) | 1999-09-01 | 2003-03-04 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 自己免疫疾患を処置するための方法および組成物 |
CN1352641A (zh) | 1999-09-29 | 2002-06-05 | 奥索-麦克尼尔药品公司 | 用于治疗整联蛋白介导的疾病的异哌啶甲酰胺 |
NZ518369A (en) | 1999-10-20 | 2003-09-26 | Tanabe Seiyaku Co | 1,3 or 1,8-Diazabicyclo octane or nonane derivatives or tricyclic derivatives useful as inhibitors of alphaL-beta2 mediated cell adhesion |
US6458822B2 (en) * | 2000-03-13 | 2002-10-01 | Pfizer Inc. | 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
US6458790B2 (en) | 2000-03-23 | 2002-10-01 | Merck & Co., Inc. | Substituted piperidines as melanocortin receptor agonists |
JP4939716B2 (ja) | 2000-04-08 | 2012-05-30 | ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト | 二環式複素環化合物、これらの化合物を含む医薬組成物、それらの使用及びそれらの調製方法 |
US6627634B2 (en) * | 2000-04-08 | 2003-09-30 | Boehringer Ingelheim Pharma Kg | Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them |
US6482840B2 (en) * | 2000-05-22 | 2002-11-19 | Merck & Co., Inc. | Substituted cyclic amidine derivatives as inhibitors of cell adhesion |
BR0111188A (pt) | 2000-05-31 | 2003-06-10 | Tanabe Seiyaku Co | Inibidores de adesão de célula mediada por alfal beta2 |
US6579889B2 (en) * | 2000-06-22 | 2003-06-17 | Merck & Co., Inc. | Substituted isonipecotyl derivatives as inhibitors of cell adhesion |
WO2002002522A1 (en) | 2000-06-29 | 2002-01-10 | Abbott Laboratories | Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
US6803370B2 (en) | 2000-07-21 | 2004-10-12 | Elan Pharmaceuticals, Inc. | Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4 |
US6689781B2 (en) | 2000-07-21 | 2004-02-10 | Elan Pharmaceuticals, Inc. | Phenylalanine derivatives as alpha 4 integrin inhibitors |
US7015216B2 (en) | 2000-07-21 | 2006-03-21 | Elan Pharmaceuticals, Inc. | Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors |
AU2002248432A1 (en) | 2001-02-14 | 2002-08-28 | Sankyo Company, Limited | Oxazole derivatives, their preparation and their use as cytokine inhibitors |
GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
JP2005022976A (ja) | 2001-07-18 | 2005-01-27 | Ajinomoto Co Inc | カルボン酸誘導体 |
AU2002320494B2 (en) | 2001-07-18 | 2006-06-29 | Merck Sharp & Dohme Corp. | Bridged piperidine derivatives as melanocortin receptor agonists |
US6646130B2 (en) * | 2001-07-19 | 2003-11-11 | Merck & Co., Inc. | Process to chiral integrin antagonist beta-amino acid intermediate |
DE10137595A1 (de) | 2001-08-01 | 2003-02-13 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung |
CA2851462A1 (en) * | 2003-01-08 | 2004-07-29 | University Of Washington | Antibacterial agents |
CA2634005C (en) | 2005-12-15 | 2012-01-03 | Vicuron Pharmaceuticals Inc. | N-hydroxyamide derivatives possessing antibacterial activity |
-
2003
- 2003-07-11 AU AU2003267991A patent/AU2003267991B2/en not_active Ceased
- 2003-07-11 EP EP03748939A patent/EP1539744A4/en not_active Withdrawn
- 2003-07-11 KR KR1020057000524A patent/KR101011373B1/ko not_active IP Right Cessation
- 2003-07-11 WO PCT/US2003/021838 patent/WO2004007444A2/en active Application Filing
- 2003-07-11 CA CA002492035A patent/CA2492035A1/en not_active Abandoned
- 2003-07-11 JP JP2004521744A patent/JP4617449B2/ja not_active Expired - Fee Related
- 2003-07-11 US US10/617,616 patent/US7691843B2/en not_active Expired - Fee Related
-
2005
- 2005-01-10 IL IL16621305A patent/IL166213A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US20080058304A1 (en) | 2008-03-06 |
WO2004007444A3 (en) | 2004-09-10 |
CA2492035A1 (en) | 2004-01-15 |
US7691843B2 (en) | 2010-04-06 |
EP1539744A4 (en) | 2007-06-06 |
KR101011373B1 (ko) | 2011-01-28 |
JP2005536510A (ja) | 2005-12-02 |
WO2004007444A2 (en) | 2004-01-22 |
EP1539744A2 (en) | 2005-06-15 |
JP4617449B2 (ja) | 2011-01-26 |
AU2003267991A1 (en) | 2004-02-02 |
KR20050023412A (ko) | 2005-03-09 |
AU2003267991B2 (en) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL166213A0 (en) | N-hydroxyamide derivatives possessing antibacterial activity | |
PT1583763E (pt) | Derivados de benzoazolilpiperazina com actividade antagonista de vr1 | |
HK1090061A1 (en) | Novel lincomycin derivatives possessing antimicrobial activity | |
IL166476A0 (en) | Lincomycin derivatives possessing antibacterial activity | |
AU2003282779A1 (en) | Antibacterial agents | |
AU2003300965A1 (en) | Antibacterial agents | |
HK1091491A1 (en) | Pyrrol derivatives with antibacterial activity | |
AU2003282268A1 (en) | Activity monitoring | |
AU2003218997A1 (en) | Macrolides with antibacterial activity | |
AU2003280129A1 (en) | Activity monitoring | |
IL153839A0 (en) | Pleuromutilin derivatives having antibacterial activity | |
IL162930A0 (en) | Wireless ecg system | |
AU2003288248A1 (en) | Dihalo-allyloxy-phenol derivatives having pesticidal activity | |
AU2003288459A1 (en) | Antibacterial agents | |
AU2003224345A1 (en) | Antibacterial agents | |
AU2003290684A1 (en) | Novel anhydrolide derivatives having antibacterial activity | |
AU2003217072A1 (en) | Antibacterial agents | |
AU2003224274A1 (en) | Human polypeptides having antibacterial activity | |
AU2002349137A1 (en) | Antibacterial agents | |
AU2003285545A1 (en) | Antibacterial agents | |
GB0204703D0 (en) | Antibacterial agent | |
GB0210439D0 (en) | Antibacterial compounds | |
GB0204853D0 (en) | Antibacterial compounds | |
GB0221809D0 (en) | Antibiotic derivatives | |
HUP0200109D0 (en) | Compounds having pharmaceutical activity |